OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Neural Transmission is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Do demographic and clinical features and comorbidities affect the risk of spread to an additional body site in functional motor disorders?	86
Alterations in metabolites in the anterior cingulate cortex and thalamus and their associations with pain and empathy in patients with chronic mild pain: a preliminary study	82
Facets of movement disorders– a tribute to Heinz Reichmann	69
Proteinopathies: molecular mechanisms and diagnostic perspectives	62
Stress enhances heartbeat-evoked potentials, independent of continuous or intermittent theta burst stimulation of the interoceptive brain network targeting the right supramarginal gyrus: a preliminary	59
Eye movement study in essential tremor patients and its clinical correlates	55
Current perspectives on brain circuits involved in food addiction-like behaviors	54
A kynurenine pathway enzyme aminocarboxymuconate-semialdehyde decarboxylase may be involved in treatment-resistant depression, and baseline inflammation status of patients predicts treatment response:	51
Sitagliptin attenuates L-dopa-induced dyskinesia by regulating mitochondrial proteins and neuronal activity in a 6-OHDA-induced mouse model of Parkinson’s disease	48
Neuromelanin granules of the substantia nigra: proteomic profile provides links to tyrosine hydroxylase, stress granules and lysosomes	48
A wearable device-enabled therapeutic approach to improve joint attention in autism spectrum disorder: a prospective pilot study	48
Contrasting features between Tourette syndrome and secondary tic disorders	42
Cholinergic neurotransmission in the brain of streptozotocin-induced rat model of sporadic Alzheimer’s disease: long-term follow up	41
Pathogenesis of Parkinson’s disease: from hints from monogenic familial PD to biomarkers	40
Distinct gait dimensions are modulated by physical activity in Parkinson's disease patients	39
Far from being the end of the road: taking a closer look at neuropalliative care in Parkinson’s disease	38
Dopamine agonists in the treatment of Parkinson's disease: the show must go on	37
Non motor Parkinson: subtypes, biomarkers, stepped care and a journal!	36
Bradykinesia and rigidity modulated by functional connectivity between the primary motor cortex and globus pallidus in Parkinson’s disease	35
Kindness in science does matter	35
Reduced vagal activity in borderline personality disorder is unaffected by intranasal oxytocin administration, but predicted by the interaction between childhood trauma and attachment insecurity	35
Camillo Golgi’s contributions to the anatomic basis of sensitivity in tendons	34
Association between autonomic dysfunction with motor and non-motor symptoms in patients with Parkinson's disease	32
The pathobiology of depression in Huntington’s disease: an unresolved puzzle	29
Comparison of inflammatory biomarker levels in neurodegenerative proteinopathies: a case-control study	28

Botulinum toxin and conservative treatment strategies in people with cervical dystonia: an online survey	28
The role of immune and inflammatory-related indicators in cognitive dysfunction and disease severity in patients with parkinson’s disease	28
Unusual delayed and prolonged arm weakness and atrophy following botulinum toxin injection for musician’s cramp: case report	28